Piperacillin-Tazobactam Induced Fanconi Syndrome

Fanconi Syndrome


Abstract views: 25 / PDF downloads: 22

Authors

DOI:

https://doi.org/10.5281/zenodo.16746834

Abstract

Letter to Editor -No Abstract

Author Biographies

Ferah Taran, Sirnak State Hospital, Department of Nephrology, Şırnak, Türkiye

Dr. Ferah Taran, Nephrology Specialist (MD),

Sirnak State Hospital, Nephrology Department, Sirnak/Türkiye

Ercan Turkmen, Ondokuz Mayis University, Division of Nephrology, Samsun, Türkiye

Dr. Ercan Turkmen, Associate Professor of Nephrology

Ondokuz Mayis University, Division of Nephrology, Samsun/Türkiye

References

Foreman JW. Fanconi Syndrome. Pediatr Clin North Am. 2019;66(1):159-167. doi:10.1016/j.pcl.2018.09.002

Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014;107(4):261-269. doi:10.1093/qjmed/hct258

Kashoor I, Batlle D. Proximal renal tubular acidosis with and without Fanconi syndrome. Kidney Res Clin Pract. 2019;38(3):267-281. doi:10.23876/j.krcp.19.056

Hieshima K, Sugiyama S, Yoshida A, et al. Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels. J Diabetes Investig. 2020;11(3):617-625. doi:10.1111/jdi.13191

Woodward CL, Hall AM, Williams IG, et al. Tenofovir-associated renal and bone toxicity. HIV Med. 2009;10(8):482-487. doi:10.1111/j.1468-1293.2009.00716.x

Blair M, Côté JM, Cotter A, Lynch B, Redahan L, Murray PT. Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review. Am J Nephrol. 2021;52(2):85-97. doi:10.1159/000513742

Seger D, Barker K, McNaughton C. Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology. Clin Toxicol (Phila). 2013;51(6):461-466. doi:10.3109/15563650.2013.811588

Downloads

Published

2025-08-06

How to Cite

Taran, F., & Turkmen, E. (2025). Piperacillin-Tazobactam Induced Fanconi Syndrome: Fanconi Syndrome. Journal of European Internal Medicine Professionals, 3(3), 140–141. https://doi.org/10.5281/zenodo.16746834

Issue

Vol. 3 No. 3 (2025): J Eur Int Med Prof

Section

Letter to Editor

Categories

License

Copyright (c) 2025 Ferah Taran, Ercan Turkmen

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)